Status:

ACTIVE_NOT_RECRUITING

Reducing Risk of Dementia Through Deprescribing

Lead Sponsor:

Indiana University

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Dementia

Alzheimer Disease, Late Onset

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety out...

Detailed Description

The R2D2 study will test whether the adverse cognitive effects of anticholinergic medications are reversible by implementing a pharmacist-based deprescribing intervention for older adults within prima...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Participants:
  • Age 65 and older;
  • At least one office visit to their primary care physician within the previous 12 months;
  • Use of a target anticholinergic medication within the last two weeks OR medical record evidence of exposure to target anticholinergic medications at or above a cognitive risk threshold in the prior 12 months
  • Able to communicate in English;
  • Access to a telephone
  • Exclusion Criteria for Participants:
  • Permanent resident of an extended care facility (nursing home)
  • Diagnosis of schizophrenia, bipolar disorder, or schizoaffective disorder defined by International Classification of Diseases (ICD) version 9/10 codes
  • Diagnosis of Alzheimer's Disease or Related Dementia as determined by (a), (b), or (c) below:
  • ICD-9/10 codes, or
  • Current use of a medication for Alzheimer's Disease or a Related Dementia, or
  • A pattern of responses to the Functional Activities Questionnaire (FAQ) that indicate dementia (i.e., ≥ 3 FAQ items are scored at "requires assistance," or if ≥ 1 FAQ item is scored at "dependent").

Exclusion

    Key Trial Info

    Start Date :

    July 20 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 30 2026

    Estimated Enrollment :

    344 Patients enrolled

    Trial Details

    Trial ID

    NCT04270474

    Start Date

    July 20 2020

    End Date

    July 30 2026

    Last Update

    March 14 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Indiana University Health

    Indianapolis, Indiana, United States, 46202

    2

    Community Health Network Foundation, Inc.

    Indianapolis, Indiana, United States, 46256